Thymosin Alpha-1 (Ta1/Zadaxin)
No pricing data available yet for this peptide.
Pricing data is updated regularly.
Thymosin Alpha-1 (TA1) is a 28-amino acid peptide that modulates immune function. It enhances T-cell function, promotes dendritic cell maturation, increases natural killer cell activity, and has anti-viral/anti-tumor properties. FDA-orphan drug approved for certain conditions in several countries.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | 0.8-1.6 mg | Twice weekly | Subcutaneous, consistent days |
| Standard | 1.6 mg | Twice weekly | Monday/Thursday or similar |
| Advanced | 1.6 mg | Daily during acute illness | Under medical supervision |
4-12 weeks, can use ongoing for chronic conditions
~2 hours
Add sterile water or bacteriostatic water
Refrigerate at 36-46°F
Refrigerate, use within 14 days
Explore peer-reviewed studies and clinical research on TA1
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.